TP53 mutations are significantly enriched in CMP-pattern MDS [14,25], whereas RUNX1, DNMT3A, BCOR, and STAG2 mutations are more prevalent in GMP-pattern MDS [15,16]. This evidence concerns the gene STAG2 and myelodysplastic syndrome.